Cardiometabolic Diseases Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Cardiovascular Disease (CVD), Type 2 diabetes, Hypertension, and Obesity), Treatment (ACE Inhibitors, Diuretics, Glucophage, and Others), Dosage (Tablet and Injection), Route of Administration (Oral and Intravenous), End Users (Hospital, Clinic, and Homecare Setting), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Geography

  • Code: RW00014668607
  • The Insight Partners
  • Oct-2021
  • Life Sciences
  • 293 Pages

Single User License $4550
Site License $6550
Enterprise License $8550

Have a Question?